首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|The role of gut microbiota and metabolomics in tacrolimus-induced metabolic diseases after liver transplantation

The role of gut microbiota and metabolomics in tacrolimus-induced metabolic diseases after liver transplantation

Zhang-Peng Feng Han-Bei Lyu Bin Chen Qing-Hong Lin Guo-Ping Jiang

Hepatobiliary & Pancreatic Diseases International2026，Vol.25Issue(4)：P.449-453,5.

Hepatobiliary & Pancreatic Diseases International2026，Vol.25Issue(4)：P.449-453,5.DOI:10.1016/j.hbpd.2026.05.005

The role of gut microbiota and metabolomics in tacrolimus-induced metabolic diseases after liver transplantation

Zhang-Peng Feng ¹Han-Bei Lyu ¹Bin Chen ²Qing-Hong Lin ¹Guo-Ping Jiang²

作者信息

1. School of Medicine,Zhejiang Chinese Medical University,Hangzhou 310053,China
2. Department of Hepatobiliary and Pancreatic Surgery,Shulan(Hangzhou)Hospital Affiliated to Zhejiang Shuren University,Shulan International MedicalCollege,Hangzhou 310022,China
折叠

摘要

关键词

immunosuppressive therapy/metabolic diseases/metabolomics/tacrolimus/maintaining graft function/diabetes mellitushy pertensiondyslipidemia/gut microbiota/liver transplantationwith

分类

医药卫生

引用本文复制引用

Zhang-Peng Feng,Han-Bei Lyu,Bin Chen,Qing-Hong Lin,Guo-Ping Jiang..The role of gut microbiota and metabolomics in tacrolimus-induced metabolic diseases after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2026,25(4):P.449-453,5.

基金项目

supported by a grant from the National Key Re-search and Development Program of China(No.2021YFA1301104). （No.2021YFA1301104）

Hepatobiliary & Pancreatic Diseases International

ISSN：1499-3872

访问量0

下载量0

段落导航